Position in GILD
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,568,201
-$423,753 QoQ
Shares Held
36,158
+0.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#600
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cornerstone Capital, Inc. holds $113,799,273 across 8 Drug Manufacturers - General names. GILD ranks #5 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
154,756 | $38,942,799 | |
| 2 | AMGN |
Amgen Inc
|
90,924 | $32,925,398 | |
| 3 | JNJ |
Johnson & Johnson
|
115,036 | $29,215,692 | |
| 4 | PFE |
Pfizer Inc
|
267,909 | $6,451,248 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
36,158 | $4,568,201 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,642 | $596,497 | |
| 7 | LLY |
ELI LILLY & Co
|
485 | $581,723 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,985 | $517,715 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,568,201 | 36,158 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $4,991,954 | 35,818 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,390,900 | 35,774 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,970,914 | 35,774 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,940,763 | 35,544 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,920,517 | 34,989 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,242,925 | 35,108 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,964,833 | 35,363 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $2,437,987 | 35,534 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,900,260 | 39,594 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $3,675,747 | 45,374 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $3,400,327 | 45,374 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,518,939 | 45,659 | Shares | Sole | 2023-08-21 | |
| 2023-03-31 | $3,746,842 | 45,159 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,782,465 | 44,059 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,637,494 | 42,754 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $2,591,631 | 41,929 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,682,919 | 45,129 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,594,921 | 49,510 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,618,928 | 51,810 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $3,224,369 | 46,825 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,033,732 | 46,940 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,770,670 | 47,557 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,012,077 | 47,667 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $3,289,723 | 42,757 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,050,656 | 40,806 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||